GSP Crop Science has filed draft red herring prospectus (DRHP) with the market regulator Securities and Exchange Board of India (SEBI) to raise funds through an initial public offering (IPO). The company's IPO is a mix of fresh issue of shares worth Rs 280 crore and an Offer For Sale (OFS) of 60 lakh equity shares by promoters.
Proceeds from the fresh issue to the tune of Rs 200 crore will be used for payment of debt and and a portion will be utilised for general corporate purposes. Equirus Capital and Motilal Oswal Investment Advisors are the book-running lead managers of the issue.
GSP Crop Science is a research-focused agrochemical company with over 39 years of expertise in developing and manufacturing insecticides, herbicides, fungicides, and plant growth regulators in India.
| Company Name | CMP |
|---|---|
| UPL | 658.55 |
| PI Industries | 3050.75 |
| Bayer CropScience | 4871.35 |
| Sharda Cropchem | 1109.00 |
| Sumitomo Chemical | 441.15 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: